好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Age-Related Memory Loss and Alzheimer's Disease: A Randomized, Interactive Web-Based 好色先生al Intervention Study
Neurologic 好色先生
S27 - (-)
006
Despite waiting room brochures and current educational efforts of physicians, patients and caregivers are concerned about cognitive decline, but do not have a clear understanding of the differences between Age-Related Memory Loss (ARML) and Alzheimer's disease (AD). A pilot study is ongoing to evaluate effectiveness of an interactive, web-based educational intervention, as well as to assess the need for such educational tools.
A brief interactive online web module presentation was created using Articulate Studio and Microsoft PowerPoint. The module provides an overview of ARML and AD, as well as various interventions that may offer therapeutic benefit against cognitive decline. Participants include patients, caregivers, medical students, and residents-in-training. Patients/caregivers are recruited via the Memory Disorders Clinic at the University of Miami Miller School of Medicine, social networking sites (e.g., www.Facebook.com), community health fairs, websites and e-mail invitations for targeted audiences interested in memory loss and AD (e.g., www.TherapyForMemory.org). Informed consent is obtained prior to participant randomization in two groups: Group 1 receives the web module intervention in addition to online educational links from the Alzheimer's Association; Group 2 only receives online access to educational links from the Alzheimer's Association. A pre-intervention assessment is completed prior to randomization, with a post-intervention quiz and survey following the education.
Although there is no significant difference between pre- and post-intervention scores, interim data is trending towards greater score improvement with the interactive learning module intervention (average point increase 11.75 versus 6.4, p=0.31).
While the study is ongoing, preliminary data suggests greater knowledge improvement and participant satisfaction with an interactive web module when compared to reading materials alone. Continued testing focuses on evaluating user perception for this educational alternative, and feasibility of implementation across a variety of settings.
Authors/Disclosures
Thomas R. Hughes
PRESENTER 		No disclosure on file
Florian Eichler, MD (Massachusetts General Hospital) An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for SwanBio Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Eichler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Swan Bio. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. Dr. Eichler has stock in SwanBio Therapeutics. The institution of Dr. Eichler has received research support from Minoryx Therpeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from bluebird bio. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals. Dr. Eichler has received intellectual property interests from a discovery or technology relating to health care.
Jun Sone, MD, PhD, FAAN (Aichi Medical University) No disclosure on file
No disclosure on file
Marytery Fajardo, MD (Nicklaus Children's Hospital) No disclosure on file
Richard S. Isaacson, MD, FAAN Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.